Book Chapters

Dara M Cannon (2010) 'MODERN TRENDS IN PHARMACOPSYCHIATRY' In: Cryan, J.; Karger, B.L (eds). [Details]

DM Cannon. '‘Neuroimaging and the pathophysiology and treatment of depression: recent advances and future needs.’' In: Editors: Prof. Brian Leonard and Dr. John Cryan (eds). Book Series: Modern Trends in Pharmacopsychiatry Psychopathology and Pharmacotherapy of Depression. . Publishers: S. Karger. [DOI] [Details]

 

Peer Reviewed Journals

Savitz J, Nugent A, Bogers W, Liu A, Sills R, Luckenbaugh D, Bain E, Price J, Zarate C, Manji H, Cannon DM, Marrett S, Charney D, Drevets WC. (2001) 'In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA'. British Journal of Pharmacology, 134 (7):1455-1460. [Details]

Murphy, J., Flynn, J. J., Cannon, D. M., Guiry, P. J., McCormack, P., Baird, A. W., McBean, G. J. & Keenan, A. K. (2002) 'In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine'. European Journal of Pharmacology, 444 (01-Feb):61-67. [Details]

Erickson, K., Drevets, W. C., Clark, L., Cannon, D. M., Bain, E. E., Zarate, C. A. Jr., Charney, D. S. and Sahakian, B. J. (2005) 'Mood-Congruent Bias in Affective Go/No-Go Performance of Unmedicated Patients With Major Depressive Disorder'. American Journal of Psychiatry, 162 :2171-2173. [Details]

Cannon, D. M., Ichise, M., Fromm, S., Nugent, A. C., Rollis, D., Gandhi, S. K., Klaver, J., Charney, D., Manji, H. & Drevets, W. C. (2006) 'Serotonin Transporter Binding in Bipolar Disorder using [ 11C]DASB and Positron emission Tomography'. Biological Psychiatry, 60 :207-217. [Details]

Dara M Cannon (2006) 'Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography'. Biol Psychiatry, 60 (3):207-217. [Details]

Dara M Cannon (2006) 'Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry'. Neuroimage, 30 (3):485-497. [Details]

Dara M Cannon (2006) 'Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder'. Arch Gen Psychiatry, 63 (7):741-747. [Details]

Salvadore G, Nugent AC, Chen G, Akula N, Yuan P, Cannon DM, Zarate CA, McMahon FJ, Manji HK, Drevets WC. (2006) 'Muscarinic Cholinergic2 Receptor Binding in Major Depressive Disorder using PET and [F-18]FP-TZTP'. Archives of General Psychiatry, 63 (241). [Details]

Dara M Cannon (2006) 'Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder'. Erratum in: Arch Gen Psychiatry, 63 (11). [Details]

Cannon DM, Keenan AK, Guiry PJ, Buon C, Baird AW, McBean GJ. (2007) 'Editorial: Neuroimaging in Psychiatry'. Ir J Psych Med, 24 (3):86-88. [Details]

Taylor Tavares, J. V., Clark, L., Cannon, D. M., Erickson, K., Drevets, W. C. & Sahakian, B. J. (2007) 'Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression'. Biological Psychiatry, 62 (8):917-924. [Details]

Cannon, DM,Ichise, M,Rollis, D,Klaver, JM,Gandhi, SK,Charney, DS,Manji, HK,Drevets, WC (2007) 'Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [C-11]DASB; Comparison with bipolar disorder'. Biological Psychiatry, 62 :870-877. [DOI] [Details]

Cannon, D. M., Ichise, M., Rollis, D., Klaver, J. M., Gandhi, S. K., Charney, D. S., Manji, H. K. & Drevets, W. C. (2007) 'Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed using PET and [ 11C]DASB; Comparison with Bipolar Disorder'. Biological Psychiatry, 62 (8):870-877. [Details]

Cannon DM. Ichise M, Fromm S, Nugent AC, Rollis D, Gandhi SK, Klaver J, Charney D, Manji H, Drevets WC. (2007) 'Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed using PET and [11C]DASB; Comparison with Bipolar Disorder'. Biol. Psych, 62 . [Details]

Cannon, D. M., Klaver, J. M., Peck, S. A., Rallis-Voak, D., Erickson, K. & Drevets, W. C. (2008) 'Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed using Positron Emission Tomography and [ 11C]NNC-112'. Neuropsychopharmacology, . [Details]

Dara M Cannon (2008) 'Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [(11)C]NNC-112'. Neuropsychopharmacology, . [Details]

Holmes, M. K., Erickson, K., Luckenbaugh, D. A., Drevets, W. C., Bain, E. E., Cannon, D. M., Snow, J., Sahakian, B. J., Manji, H. K. & Zarate, C. A. (2008) 'A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression'. Bipolar Disorders, . [Details]

CANNON, DM et al. (2009) 'Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [C-11]NNC-112'. NEUROPSYCHOPHARMACOLOGY, 34 :1277-1287. [DOI] [Details]

Roiser J, Cannon DM, Gandhi SK, Taylor Tavares J, Erickson K, Wood S, Klaver JK, Zarate C, Clark L, Sahakian BJ, Drevets WC. (2009) 'Bcl-2 polymorphism influences gray matter volume in the ventral striatum in healthy humans'. Biological Psychiatry 2, 66 (8):804-807. [DOI] [Details]

Nugent AC, Milham MP, Bain EE, Mah L, Cannon DM, Marrett S, Zarate CA, Pine DS, Price JL, Drevets WC. (2009) 'Hot and Cold Cognition in Unmedicated Depressed Subjects with Bipolar Disorder'. Bipolar Disord, 11 (2):178-189. [Details]

Dara M Cannon (2009) 'Bcl-2 polymorphism influences gray matter volume in the ventral striatum in healthy humans'. Biol Psychiatry, 66 (8):804-807. [Details]

Laje G*, Cannon DM*, Allen AS, Klaver JM, Peck SA, Liu X, Manji HK, Drevets WC, McMahon FJ. (2010) 'Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB'. Int J Neuropsychopharmacol. - Joint first authors contributed equally to this work, 13 (6):7`5-724. [Details]

Migle Makelyte1, Sarah Hehir2, Helen Casey2, Liam Kilmartin1, Camilla Langan2, John McFarland2, Ahmed Mohammed2, Louise Emsell2, Heike Schmidt2, Laurena Holleran2, Peter McCarthy3, Gareth Barker4, Colm McDonald2, Dara M. Cannon2. (2010) 'Automated versus Manual Segmentation of the Human Caudate and Hippocampus'. Conference: Neuroscience Ireland, . [Details]

Dara M Cannon (2010) 'Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia'. Neuropsychopharmacology, 35 (2):368-373. [Details]

Dara M Cannon (2010) 'Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication'. Neuroimage. 2010 Feb 15;49(4):2966-76, 49 (4):2966-2976. [Details]

Cannon DM, Klaver JM, Peck SA, Rallis D, Erickson K, Drevets WC. (2010) 'Habenula Volume in Bipolar Disorder and Major Depressive Disorder: A High-Resolution Magnetic Resonance Imaging Study'. Biol Psychiatry, . [Details]

Dara M Cannon (2010) 'Genetic variation in cholinergic muscarinic-2 receptor gene modulates M(2) receptor binding in vivo and accounts for reduced binding in bipolar disorder'. Mol Psychiatry, . [Details]

Taylor Tavares JV, Clark L, Cannon DM, Erickson K, Drevets WC, Sahakian BJ. (2010) 'Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: The impact of medication'. Neuroimage, 49 :2966-2976. [DOI] [Details]

Savitz JB, Nugent AC, Bogers W, Roiser JP, Bain EE, Neumeister A, Zarate CA Jr, Manji HK, Cannon DM, Marrett S, Henn F, Charney DS, Drevets WC. (2011) 'Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study'. Biol Psychiatry, 69 (4):336-343. [DOI] [Details]

Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM, Neumeister A, Zarate CA Jr, Drevets WC. (2011) 'Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder'. Neuroimage, 54 (4):2643-2651. [DOI] [Details]

Cannon DM, Klaver JK, Gandhi SK, Solorio G, Peck SA, Erickson K, N Akula JS, Eckelman WC, Furey ML, Sahakian BJ, McMahon FJ, Drevets WC (2011) 'Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder'. Mol Psychiatry, 16 (4):407-418. [DOI] [Details]

Dara M Cannon 'A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression'. . [Details]

Cannon DM, Ichise M, Charney DS, Manji HK, Drevets WC. 'Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder'. Neuroimage, . [Details]

 

Conference Publications

Cannon, DM,Klaver, JM,Peck, SA,Carlson, PJ,Luckenbaugh, D,Ichise, M,Drevets, WC (2009) BIOLOGICAL PSYCHIATRY Serotonin Transporter Binding in Panic Disorder: A [C-11]DASB PET Study , pp.85-85 [Details]

McFarland J, Cannon DM, Schmidt H, Ahmed M, Hehir S, Emsell L, McCarthy P, McDonald C. (2010) Variation in grey matter volume with degree of insight in first episode psychosis and chronic schizophrenia [Details]

Laurena Holleran1, Ahmed Mohammed1, Heike Schmidt1, John McFarland1, Alexander Leemans2, Peter McCarthy1, Louise Emsell1, Gareth J. Barker3, Colm McDonald1, Dara M. Cannon1. (2011) Widespread Microstructural White Matter Alterations in Treatment Resistance Schizophrenia: A DTI Study.: [Details]